These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 32801088

  • 41. Recent development and strategies towards target interactions: Synthesis, characterization and in silico analysis of benzimidazole based thiadiazole as potential anti-Alzheimer agents.
    Khan S, Hussain R, Iqbal T, Rahim F, Khan Y.
    Biochem Biophys Res Commun; 2024 Sep 24; 726():150201. PubMed ID: 38924881
    [Abstract] [Full Text] [Related]

  • 42. Novel Iodinated Hydrazide-hydrazones and their Analogues as Acetyl- and Butyrylcholinesterase Inhibitors.
    Krátký M, Štěpánková Š, Brablíková M, Svrčková K, Švarcová M, Vinšová J.
    Curr Top Med Chem; 2020 Sep 24; 20(23):2106-2117. PubMed ID: 32814531
    [Abstract] [Full Text] [Related]

  • 43. Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease.
    Kurt BZ, Gazioglu I, Basile L, Sonmez F, Ginex T, Kucukislamoglu M, Guccione S.
    Eur J Med Chem; 2015 Sep 18; 102():80-92. PubMed ID: 26244990
    [Abstract] [Full Text] [Related]

  • 44. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S, Khan IU, Bajda M, Ashraf M, Qurat-Ul-Ain, Shaukat A, Rehman TU, Mutahir S, Hussain S, Mustafa G, Yar M.
    Bioorg Chem; 2015 Dec 18; 63():64-71. PubMed ID: 26451651
    [Abstract] [Full Text] [Related]

  • 45. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF, Lushchekina SV, Boltneva NP, Serebryakova OG, Rudakova EV, Ustyugov AA, Bachurin SO, Shchepochkin AV, Chupakhin ON, Charushin VN, Richardson RJ.
    Bioorg Med Chem; 2017 Nov 01; 25(21):5981-5994. PubMed ID: 28986116
    [Abstract] [Full Text] [Related]

  • 46. Synthesis of imperatorin analogs and their evaluation as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Granica S, Kiss AK, Jarończyk M, Maurin JK, Mazurek AP, Czarnocki Z.
    Arch Pharm (Weinheim); 2013 Nov 01; 346(11):775-82. PubMed ID: 24123207
    [Abstract] [Full Text] [Related]

  • 47. Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
    Lane RM, Potkin SG, Enz A.
    Int J Neuropsychopharmacol; 2006 Feb 01; 9(1):101-24. PubMed ID: 16083515
    [Abstract] [Full Text] [Related]

  • 48. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
    Yu YF, Huang YD, Zhang C, Wu XN, Zhou Q, Wu D, Wu Y, Luo HB.
    ACS Chem Neurosci; 2017 Nov 15; 8(11):2522-2534. PubMed ID: 28783948
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA, Ojo AB, Okolie C, Nwakama MC, Iyobhebhe M, Evbuomwan IO, Nwonuma CO, Maimako RF, Adegboyega AE, Taiwo OA, Alsharif KF, Batiha GE.
    Molecules; 2021 Apr 01; 26(7):. PubMed ID: 33915968
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors.
    Chen SC, Qiu GL, Li B, Shi JB, Liu XH, Tang WJ.
    Eur J Med Chem; 2018 Mar 10; 147():194-204. PubMed ID: 29438888
    [Abstract] [Full Text] [Related]

  • 53. Aaptamine - a dual acetyl - and butyrylcholinesterase inhibitor as potential anti-Alzheimer's disease agent.
    Miao S, He Q, Li C, Wu Y, Liu M, Chen Y, Qi S, Gong K.
    Pharm Biol; 2022 Dec 10; 60(1):1502-1510. PubMed ID: 35968601
    [Abstract] [Full Text] [Related]

  • 54. Acetylcholinesterase and butyrylcholinesterase inhibitory activities of antioxidant peptides obtained from enzymatic pea protein hydrolysates and their ultrafiltration peptide fractions.
    Asen ND, Aluko RE.
    J Food Biochem; 2022 Nov 10; 46(11):e14289. PubMed ID: 35758753
    [Abstract] [Full Text] [Related]

  • 55. In silico exploration of promising heterocyclic molecules against both acetylcholinesterase and butyrylcholinesterase enzymes.
    Nguyen HD, Kim MS.
    J Biomol Struct Dyn; 2024 Sep 10; 42(14):7128-7149. PubMed ID: 37477246
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB, Aguan K, Mitra S, Bhattacharjee A.
    J Biomol Struct Dyn; 2017 Jun 10; 35(8):1729-1742. PubMed ID: 27410776
    [Abstract] [Full Text] [Related]

  • 58. Exploration of dual fatty acid amide hydrolase and cholinesterase inhibitory potential of some 3-hydroxy-3-phenacyloxindole analogs.
    Tripathi RKP, Ayyannan SR.
    Arch Pharm (Weinheim); 2020 Sep 10; 353(9):e2000036. PubMed ID: 32573008
    [Abstract] [Full Text] [Related]

  • 59. A modified binary particle swarm optimization with a machine learning algorithm and molecular docking for QSAR modelling of cholinesterase inhibitors.
    Shamsi E, Rahati A, Dehghanian E.
    SAR QSAR Environ Res; 2021 Sep 10; 32(9):745-767. PubMed ID: 34494463
    [Abstract] [Full Text] [Related]

  • 60. Design, synthesis and preliminary structure-activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives.
    Liu H, Fan H, Gao X, Huang X, Liu X, Liu L, Zhou C, Tang J, Wang Q, Liu W.
    J Enzyme Inhib Med Chem; 2016 Aug 10; 31(4):580-9. PubMed ID: 26186269
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.